{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:19Z","timestamp":1791314359167,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3081,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/mt.2008.50","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T18:27:54Z","timestamp":1207247274000},"page":"947-956","source":"Crossref","is-referenced-by-count":141,"title":["AAV Vector\u2013mediated RNAi of Mutant Huntingtin Expression Is Neuroprotective in a Novel Genetic Rat Model of Huntington's Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Nicholas R","family":"Franich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahna M","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Klugmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"During","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2008.50_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1038\/mt.2008.50_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu Rev Neurosci"},{"key":"10.1038\/mt.2008.50_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2008.50_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1038\/mt.2008.50_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0166-2236(00)01954-8","article-title":"Viral-based gene transfer to the mammalian CNS for functional genomic studies","volume":"24","author":"Janson","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2008.50_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0166-2236(03)00164-4","article-title":"Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors","volume":"26","author":"Kirik","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2008.50_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","article-title":"Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain","volume":"20","author":"Senut","year":"2000","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2008.50_bib8","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2008.50_bib9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib10","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.50_bib11","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.50_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2006.02.141","article-title":"rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse","volume":"343","author":"Machida","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2008.50_bib13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntingtin's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2008.50_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res"},{"key":"10.1038\/mt.2008.50_bib16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1038\/mt.2008.50_bib17","first-page":"309","article-title":"Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum","volume":"50","author":"Harrington","year":"1991","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2008.50_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ymthe.2005.10.008","article-title":"Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins","volume":"13","author":"Klein","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/mthe.2001.0520","article-title":"Targeted retrograde gene delivery for neuronal protection","volume":"5","author":"Kaspar","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib21","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1093\/nar\/30.10.e46","article-title":"RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase","volume":"30","author":"Donze","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2008.50_bib22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1261\/rna.25706","article-title":"Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity","volume":"12","author":"Jackson","year":"2006","journal-title":"RNA"},{"key":"10.1038\/mt.2008.50_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci Res"},{"key":"10.1038\/mt.2008.50_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mt.2008.50_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1038\/mt.2008.50_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1038\/mt.2008.50_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic miceexpressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2008.50_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1038\/mt.2008.50_bib29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2008.50_bib30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1566523054065057","article-title":"New recombinant serotypes of AAV vectors","volume":"5","author":"Gao","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2008.50_bib32","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","article-title":"Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system","volume":"97","author":"Davidson","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.50_bib33","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1128\/JVI.78.13.6808-6817.2004","article-title":"Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats","volume":"78","author":"Paterna","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.50_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hum.2006.178","article-title":"Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain","volume":"18","author":"Taymans","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.50_bib35","doi-asserted-by":"crossref","first-page":"8446","DOI":"10.1128\/JVI.76.16.8446-8454.2002","article-title":"Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain","volume":"76","author":"Mastakov","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.50_bib36","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.171251798","article-title":"Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems","volume":"98","author":"Caplen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2008.50_bib37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nbt739","article-title":"siRNA-mediated gene silencing in vitro and in vivo","volume":"20","author":"Xia","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2008.50_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2006.160","article-title":"High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo","volume":"18","author":"Huang","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.50_bib39","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia","volume":"10","author":"Xia","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/mt.2008.50_bib40","first-page":"119","article-title":"Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications","volume":"99","author":"Grieger","year":"2005","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10.1038\/mt.2008.50_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.gt.3302690","article-title":"Viral-based modelling and correction of neurodegenerative diseases by RNA interference","volume":"13","author":"Raoul","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2008.50_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1046-2023(02)00227-X","article-title":"Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain","volume":"28","author":"Fitzsimons","year":"2002","journal-title":"Methods"},{"key":"10.1038\/mt.2008.50_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1038\/mt.2008.50_bib44","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1525-0016(03)00012-1","article-title":"Generation and characterization of chimeric recombinant AAV vectors","volume":"7","author":"Hauck","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.50_bib46","first-page":"221","article-title":"Development and optimization of adeno-associated virus vector transfer into the central nervous system","volume":"76","author":"During","year":"2003","journal-title":"Methods Mol Med"},{"key":"10.1038\/mt.2008.50_bib47","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616317105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616317105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T21:26:50Z","timestamp":1557437210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616317105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1525001616317105"],"URL":"https:\/\/doi.org\/10.1038\/mt.2008.50","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}